The present invention provides a new imidazole derivative represented by the following formula or a pharmaceutically acceptable salt thereof which exhibits potent antimicrobial activity based on a LpxC-inhibiting action against gram-negative bacteria such as Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae, and their drug-resistant strains.
本发明提供了一种由下式表示的新
咪唑衍
生物或其药学上可接受的盐,该衍
生物具有基于 LpxC 抑制作用的强效抗菌活性,可对抗革兰氏阴性菌,如
铜绿假单胞菌、大肠埃希菌和肺炎克雷伯菌及其耐药菌株。